North Star Investment Management’s Cocrystal Pharma COCP Stock Holding History

North Star Investment Management’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-188	Closed	-$3K	–	1098
2021 Q1	$3K	Hold	188	–	–	﹤0.01%	943
2020 Q4	$3K	Hold	188	–	–	﹤0.01%	913
2020 Q3	$2K	Hold	188	–	–	﹤0.01%	929
2020 Q2	$3K	Hold	188	–	–	﹤0.01%	868
2020 Q1	$2K	Hold	188	–	–	﹤0.01%	913
2019 Q4	$1K	Hold	188	–	–	﹤0.01%	1015
2019 Q3	$5K	Buy	+188	New	+$4.87K	﹤0.01%	914
2019 Q2	–	Sell	-188	Closed	-$6K	–	489
2019 Q1	$6K	Hold	188	–	–	﹤0.01%	892
2018 Q4	$8K	Hold	188	–	–	﹤0.01%	826
2018 Q3	$6K	Sell	188 -20	-10%	-$895	﹤0.01%	907
2018 Q2	$9K	Buy	+208	New	+$7.72K	﹤0.01%	871

Other funds holding COCP

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

North Star Investment Management's COCP Position: Q2 2021 in Review

North Star Investment Management sold out of Cocrystal Pharma (COCP) in Q2 2021, closing a stake of 188 shares — an estimated $3K sold.

North Star Investment Management first reported a position in COCP in Q2 2018 and held it in 11 quarters. The position peaked at $9K in Q2 2018. 42 funds tracked by Wall St. Rank hold COCP as of Q2 2021.

North Star Investment Management reported no remaining Cocrystal Pharma position as of Q2 2021 after selling out during the quarter.
North Star Investment Management sold 188 Cocrystal Pharma shares in Q2 2021, an estimated $3K.
North Star Investment Management first reported a position in Cocrystal Pharma in Q2 2018 and held it in 11 quarters.
North Star Investment Management's Cocrystal Pharma position peaked at $9K in Q2 2018.
42 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2021.

Based on North Star Investment Management's 13F filing for Q2 2021, filed 13 Jul 2021.